3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Neoplasms
6
Venous Thromboembolism
3
Venous Thrombosis
2
Thrombosis
2
Thromboembolism
2
Prostatic Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Sarcoma, Alveolar Soft Part
1
Pulmonary Embolism
1
Prostate Cancer Patients
1
Pharmacokinetics of MDV3100
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Hematologic Neoplasms
1
Embolism and Thrombosis
1
Embolism
1
Cytochrome P450 Interaction
1
Advanced Solid Tumor
1
ALK-positive Advanced Tumors
1
Interventions
Dalteparin
11
apixaban
9
Enoxaparin
7
edoxaban
5
Tinzaparin
5
Rivaroxaban
4
Heparin, Low-Molecular-Weight
4
Dabigatran
3
bemiparin
2
abelacimab
2
Warfarin
2
Nadroparin
2
MAA868
2
Fondaparinux
2
reviparin
1
myotubularin
1
isoquercitrin
1
certoparin
1
atezolizumab
1
acarboxyprothrombin
1
Ultrasonography, Doppler, Duplex
1
Rosuvastatin Calcium
1
Phenprocoumon
1
Models, Biological
1
Medication Therapy Management
1
Intermittent Pneumatic Compression Devices
1
Imaging, Three-Dimensional
1
Hospitals
1
Heparin
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Venous Thrombosis
×
Warfarin
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled